Paper409448
Agonist and antagonist properties of buprenorphine, a new antinociceptive agent.
Cowan A and 2 others. Br J Pharmacol, 1977. Cited by 504 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Agonist and antagonist properties of buprenorphine, a new antinociceptive agent. Papers, record 409448. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/409448
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Analgesics | Major topic |
| Morphinans | Major topic |
| Narcotic Antagonists | Major topic |
| Animals | |
| Catalepsy | |
| Drug Tolerance | |
| Erythrocebus patas | |
| Haplorhini | |
| Humans | |
| Male | |
| Mice | |
| Mice, Inbred Strains | |
| Morphine Dependence | |
| Papio | |
| Rats | |
| Reaction Time | |
| Substance-Related Disorders |
Source PubMed
References17
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 13,642,264 | Antagonism of the frequency of phenylquinone-induced writhing in the mouse by weak analgesics and nonanalgesics. | J Pharmacol Exp Ther | 1959 | https://conductscience.org/library/papers/13642264 | PubMed |
| 2 | 13,465,302 | Affinity, intrinsic activity and drug interactions. | Pharmacol Rev | 1957 | https://conductscience.org/library/papers/13465302 | PubMed |
| 3 | 409,449 | The animal pharmacology of buprenorphine, an oripavine analgesic agent. | Br J Pharmacol | 1977 | https://conductscience.org/library/papers/409449 | PubMed |
| 4 | 4,550,324 | Evaluation of nalbuphine for abuse potential. | Clin Pharmacol Ther | 1972 | https://conductscience.org/library/papers/4550324 | PubMed |
| 5 | 4,472,146 | Induction of physical dependence on morphine, codeine and meperidine in the rat by continuous infusion. | J Pharmacol Exp Ther | 1974 | https://conductscience.org/library/papers/4472146 | PubMed |
| 6 | 4,211,992 | Evaluation in nonhuman primates: evaluation of the physical dependence capacities of oripavine-thebaine partial agonists in patas monkeys. | Adv Biochem Psychopharmacol | 1973 | https://conductscience.org/library/papers/4211992 | PubMed |
| 7 | 5,168,272 | Analgesic and dependence studies with oripavine partial agonists. | Br J Pharmacol | 1971 | https://conductscience.org/library/papers/5168272 | PubMed |
| 8 | 5,103,484 | The mouse jumping test--a simple screening method to estimate the physical dependence capacity of analgesics. | Arch Int Pharmacodyn Ther | 1971 | https://conductscience.org/library/papers/5103484 | PubMed |
| 9 | 4,910,901 | Effects of short- and long-term administration of pentazocine in man. | Clin Pharmacol Ther | 1970 | https://conductscience.org/library/papers/4910901 | PubMed |
| 10 | 4,394,803 | The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests. | J Pharmacol Exp Ther | 1970 | https://conductscience.org/library/papers/4394803 | PubMed |
| 11 | 943,794 | Comparison of withdrawal precipitating properties of various morphine antagonists and partial agonists in relation to their stereospecific binding to brain homogenates. | Psychopharmacologia | 1976 | https://conductscience.org/library/papers/943794 | PubMed |
| 12 | 6,688 | Use of the mouse jumping test for estimating antagonistic potencies of morphine antagonists. | J Pharm Pharmacol | 1976 | https://conductscience.org/library/papers/6688 | PubMed |
| 13 | 238,862 | Rates of onset and offset of action of narcotic analgesics in isolated preparations. | Eur J Pharmacol | 1975 | https://conductscience.org/library/papers/238862 | PubMed |
| 14 | 4,797,644 | Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats. | Psychopharmacologia | 1973 | https://conductscience.org/library/papers/4797644 | PubMed |
| 15 | 4,958,020 | The pharmacology of N-(cyclopropylmethyl)-19-isopentylnororvinol hydrochloride. A potent and long lasting central depressant. | Br J Pharmacol Chemother | 1966 | https://conductscience.org/library/papers/4958020 | PubMed |
| 16 | 945,347 | The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. | J Pharmacol Exp Ther | 1976 | https://conductscience.org/library/papers/945347 | PubMed |
| 17 | 5,472,209 | Studies on the receptors involved in the action of the various agents in the phenylbenzoquinone analgesic assay in mice. | Br J Pharmacol | 1970 | https://conductscience.org/library/papers/5472209 | PubMed |
Cited by148
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 504 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,720,725 | Brixadi for Stimulant Use Disorder: Evolving Pharmacologic Considerations and Clinical Implications. | Adv Ther | 2026 | https://conductscience.org/library/papers/42720725 | PubMed |
| 42,638,138 | Evaluation of a human slow-release buprenorphine formulation in rats - tactile sensitivity and plasma concentration. | Lab Anim Res | 2026 | https://conductscience.org/library/papers/42638138 | PubMed |
| 41,072,817 | Antidepressants and the endogenous opioid system. | Biochem Pharmacol | 2025 | https://conductscience.org/library/papers/41072817 | PubMed |
| 40,987,461 | Pharmacokinetic Evaluation of Topical Long-Acting Buprenorphine in New Zealand White Rabbits (Oryctolagus cuniculus). | J Am Assoc Lab Anim Sci | 2025 | https://conductscience.org/library/papers/40987461 | PubMed |
| 40,730,064 | N-(3-Hydroxyphenyl)-3,8-diazabicyclooctanes as opioid receptors probes. 1. Investigation of the phenolic hydroxyl group. | Eur J Med Chem | 2025 | https://conductscience.org/library/papers/40730064 | PubMed |
| 39,873,915 | Buprenorphine Pharmacodynamics: A Bridge to Understanding Buprenorphine Clinical Benefits. | Drugs | 2025 | https://conductscience.org/library/papers/39873915 | PubMed |
| 39,698,260 | Discovery of 6α-Thiazolylcarboxamidonaltrexamine Derivative (NTZ) as a Potent and Central Nervous System Penetrant Opioid Receptor Modulator with Drug-like Properties for Potential Treatment of Opioid Use Disorder. | ACS Pharmacol Transl Sci | 2024 | https://conductscience.org/library/papers/39698260 | PubMed |
| 39,667,424 | Insurmountable antagonism of human mu opioid receptors by buprenorphine is due to hemi-equilibrium. | Eur J Pharmacol | 2025 | https://conductscience.org/library/papers/39667424 | PubMed |
| 39,341,201 | A deep learning framework combining molecular image and protein structural representations identifies candidate drugs for pain. | Cell Rep Methods | 2024 | https://conductscience.org/library/papers/39341201 | PubMed |
| 38,810,170 | Searching for Synthetic Opioid Rescue Agents: Identification of a Potent Opioid Agonist with Reduced Respiratory Depression. | J Med Chem | 2024 | https://conductscience.org/library/papers/38810170 | PubMed |
| 38,796,302 | Pharmacokinetic Evaluation of a Topical Extended-release Analgesic in Mice. | J Am Assoc Lab Anim Sci | 2024 | https://conductscience.org/library/papers/38796302 | PubMed |
| 38,512,918 | Development of opioid analgesic tolerance in rat to extended-release buprenorphine formulated for laboratory subjects. | PLoS One | 2024 | https://conductscience.org/library/papers/38512918 | PubMed |
| 37,687,205 | Ligand-Free Signaling of G-Protein-Coupled Receptors: Physiology, Pharmacology, and Genetics. | Molecules | 2023 | https://conductscience.org/library/papers/37687205 | PubMed |
| 37,368,758 | Long-Acting Opioid Analgesics for Acute Pain: Pharmacokinetic Evidence Reviewed. | Vet Sci | 2023 | https://conductscience.org/library/papers/37368758 | PubMed |
| 36,411,938 | Effects of buprenorphine on acute pain and inflammation in the adjuvant-induced monoarthritis rat model. | Heliyon | 2022 | https://conductscience.org/library/papers/36411938 | PubMed |
| 36,341,476 | Endogenous opioid systems alterations in pain and opioid use disorder. | Front Syst Neurosci | 2022 | https://conductscience.org/library/papers/36341476 | PubMed |
| 35,489,781 | Role of Efficacy as a Determinant of Locomotor Activation by Mu Opioid Receptor Ligands in Female and Male Mice. | J Pharmacol Exp Ther | 2022 | https://conductscience.org/library/papers/35489781 | PubMed |
| 35,454,388 | Leptin in the Commissural Nucleus of the Tractus Solitarius (cNTS) and Anoxic Stimulus in the Carotid Body Chemoreceptors Increases cNTS Leptin Signaling Receptor and Brain Glucose Retention in Rats. | Medicina (Kaunas) | 2022 | https://conductscience.org/library/papers/35454388 | PubMed |
| 35,214,192 | Multicenter Observational/Exploratory Study Addressed to the Evaluation of the Effectiveness and Safety of Pharmacological Therapy in Opioid-Dependent Patients in Maintenance Therapy in Southern Italy. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35214192 | PubMed |
| 35,025,864 | Effects of buprenorphine on model development in an adjuvant-induced monoarthritis rat model. | PLoS One | 2022 | https://conductscience.org/library/papers/35025864 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/409448
GET https://conductscience.org/api/papers/v1/409448/cited_by?page=2